Technical Analysis for CNTG - Centogene N.V.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Volume Surge | Other | 0.00% | |
Outside Day | Range Expansion | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Gapped Up | Strength | 0.00% | |
NR7 | Range Contraction | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Inside Day | Range Contraction | 0.10% | |
Wide Bands | Range Expansion | 0.10% |
Alert | Time |
---|---|
60 Minute Opening Range Breakdown | about 7 hours ago |
2x Volume Pace | about 11 hours ago |
1.5x Volume Pace | about 11 hours ago |
3x Volume Pace | about 11 hours ago |
10x Volume Pace | about 11 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 12/20/2023
Centogene BV is a commercial-stage company. It focuses on rare diseases that transform real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies. It operates through the following two segments: Pharmaceutical and Diagnostics. The Pharmaceutical segment provides services to pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery and patient monitoring. The Diagnostics segment provides targeted genetic sequencing and diagnostics services. The company was founded by Arndt Rolf and Christoph Ehlers in 2006 and is headquartered in Rostock, Denmark.
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Pharmaceutical Rare Diseases Biomarkers Recruitment Pharmaceutical Partners Diagnostics Services
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Pharmaceutical Rare Diseases Biomarkers Recruitment Pharmaceutical Partners Diagnostics Services
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 2.52 |
52 Week Low | 0.61 |
Average Volume | 23,310 |
200-Day Moving Average | 1.08 |
50-Day Moving Average | 0.97 |
20-Day Moving Average | 0.75 |
10-Day Moving Average | 0.69 |
Average True Range | 0.08 |
RSI (14) | 34.64 |
ADX | 24.06 |
+DI | 16.82 |
-DI | 18.21 |
Chandelier Exit (Long, 3 ATRs) | 0.75 |
Chandelier Exit (Short, 3 ATRs) | 0.85 |
Upper Bollinger Bands | 0.93 |
Lower Bollinger Band | 0.57 |
Percent B (%b) | 0.36 |
BandWidth | 47.40 |
MACD Line | -0.08 |
MACD Signal Line | -0.09 |
MACD Histogram | 0.0118 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.79 | ||||
Resistance 3 (R3) | 0.80 | 0.77 | 0.77 | ||
Resistance 2 (R2) | 0.77 | 0.75 | 0.77 | 0.77 | |
Resistance 1 (R1) | 0.74 | 0.74 | 0.73 | 0.73 | 0.76 |
Pivot Point | 0.71 | 0.71 | 0.71 | 0.71 | 0.71 |
Support 1 (S1) | 0.68 | 0.69 | 0.67 | 0.67 | 0.64 |
Support 2 (S2) | 0.65 | 0.68 | 0.65 | 0.63 | |
Support 3 (S3) | 0.62 | 0.65 | 0.63 | ||
Support 4 (S4) | 0.61 |